Premium
All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis
Author(s) -
Zhu Hongming,
Hu Jiong,
Li Xiaoyang,
Chen Li,
Zhao Huijin,
Zhou Wei,
Wang Lining,
Zhao Xia,
Zhang Yunxiang,
Chen Yu,
Sun Huiping,
Chen Qiusheng,
Chen Yu,
Zhao Weili,
Mi Jianqing,
Shen Zhixiang,
Chen Zhu,
Wang Zhenyi,
Li Junmin,
Chen Saijuan
Publication year - 2015
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13375
Subject(s) - multivariate analysis , acute promyelocytic leukemia , medicine , retinoic acid , tretinoin , multivariate statistics , oncology , arsenic , pediatrics , chemistry , biochemistry , gene , organic chemistry , statistics , mathematics